Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Access to the study page now shows a 403 Forbidden error, replacing the study content with an access-denied screen. The page content includes explicit 403 messaging and related HTML structure indicating forbidden access.
    Difference
    18%
    Check dated 2026-09-19T22:16:06.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now shows revision: v3.6.6, replacing v3.6.5, indicating a minor update to the page's documentation or underlying system. This change does not modify study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:18.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This appears to be a minor platform/documentation update with no visible changes to the trial details or content.
    Difference
    0.1%
    Check dated 2026-08-08T17:03:51.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.4, replacing the previous v3.6.3, indicating a minor update to the study record page. This appears to be a backend or formatting update rather than changes to the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-25T08:27:12.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page revision label updated to v3.6.3, replacing v3.6.2. This reflects a minor internal update to the study page without altering visible content.
    Difference
    0.1%
    Check dated 2026-07-03T22:53:38.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.2, replacing the prior v3.6.0. This indicates a small update to the page template or underlying system without altering study details or data presented.
    Difference
    0.1%
    Check dated 2026-06-26T23:22:03.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.